000120666 001__ 120666
000120666 005__ 20240228145459.0
000120666 0247_ $$2doi$$a10.1016/j.ejca.2016.12.020
000120666 0247_ $$2pmid$$apmid:28335889
000120666 0247_ $$2ISSN$$a0014-2964
000120666 0247_ $$2ISSN$$a0959-8049
000120666 0247_ $$2ISSN$$a1879-0852
000120666 0247_ $$2ISSN$$a1879-2995
000120666 037__ $$aDKFZ-2017-01092
000120666 041__ $$aeng
000120666 082__ $$a610
000120666 1001_ $$0P:(DE-He78)b12aaacaa142dabed85c6d84d00bf0fb$$aSchroeder, Lea$$b0$$eFirst author
000120666 245__ $$aHuman papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.
000120666 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2017
000120666 3367_ $$2DRIVER$$aarticle
000120666 3367_ $$2DataCite$$aOutput Types/Journal article
000120666 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1661166392_30405
000120666 3367_ $$2BibTeX$$aARTICLE
000120666 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000120666 3367_ $$00$$2EndNote$$aJournal Article
000120666 520__ $$aPatients with neck squamous cell carcinomas of unknown primary tumour (NSCCUP) present with lymph node metastasis without evidence for a primary tumour. Most patients undergo an aggressive multimodal treatment, which induces severe, potentially unnecessary toxicity. Primary tumours of NSCCUP can be hidden in the oropharynx. Human papillomavirus (HPV) is causally involved in a subgroup of oropharyngeal squamous cell carcinomas (OPSCC) associated with early lymph node metastasis and good prognosis. Detection of markers for HPV transformation in NSCCUP could allow focussing on the oropharynx in primary tumour search and could be of value for choice and extent of treatment. In a retrospective multicentre study (Germany, Italy and Spain), we analysed metastatic lymph nodes from 180 NSCCUP patients for the presence of HPV DNA, HPV E6*I mRNA and cellular p16(INK4a) overexpression, a surrogate marker for HPV-induced transformation. HPV status, defined as positivity for viral mRNA with at least one additional marker, was correlated with clinical parameters and survival outcome. A substantial proportion (16%) of NSCCUP were HPV-driven, mainly by HPV16 (89%). HPV prevalence increased with year of diagnosis from 9% during 1998-2004 to 23% during 2005-2014 (p = 0.007). HPV-driven NSCCUP had significantly better overall and progression-free survival rates (p ≤ 0.008). Based on this survival benefit, it is contended that HPV RNA status should be included in NSCCUP diagnosis and in therapeutic decision-making. Deintensification of radiation in patients with HPV-driven NSCCUP, while concurrently concentrating on the oropharynx appears to be a promising therapeutic strategy, the efficacy of which should be assessed in prospective trials. To our knowledge, this is the largest study on HPV in NSCCUP.
000120666 536__ $$0G:(DE-HGF)POF3-316$$a316 - Infections and cancer (POF3-316)$$cPOF3-316$$fPOF III$$x0
000120666 588__ $$aDataset connected to CrossRef, PubMed,
000120666 7001_ $$aBoscolo-Rizzo, Paolo$$b1
000120666 7001_ $$aDal Cin, Elisa$$b2
000120666 7001_ $$aRomeo, Salvatore$$b3
000120666 7001_ $$0P:(DE-HGF)0$$aBaboci, Lorena$$b4
000120666 7001_ $$aDyckhoff, Gerhard$$b5
000120666 7001_ $$0P:(DE-He78)2e5f34f1c58eda4787a14c9dc139ca5f$$aHess, Jochen$$b6
000120666 7001_ $$aLucena-Porcel, Carlota$$b7
000120666 7001_ $$0P:(DE-He78)4e65d94adf590f6462ef8e3aa8d7f56f$$aByl, Anne$$b8
000120666 7001_ $$0P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab$$aBecker, Nikolaus$$b9
000120666 7001_ $$aAlemany, Laia$$b10
000120666 7001_ $$aCastellsagué, Xavier$$b11
000120666 7001_ $$aQuer, Miquel$$b12
000120666 7001_ $$aLeón, Xavier$$b13
000120666 7001_ $$0P:(DE-He78)1042737c83ba70ec508bdd99f0096864$$aWiesenfarth, Manuel$$b14
000120666 7001_ $$0P:(DE-He78)d99bad949ba3ae93859eedae5ac266da$$aPawlita, Michael$$b15
000120666 7001_ $$0P:(DE-He78)d84ca2cd7f160904c387ee699735076c$$aHolzinger, Dana$$b16$$eLast author
000120666 773__ $$0PERI:(DE-600)1468190-0$$a10.1016/j.ejca.2016.12.020$$gVol. 74, p. 73 - 81$$p73 - 81$$tEuropean journal of cancer$$v74$$x0959-8049$$y2017
000120666 909CO $$ooai:inrepo02.dkfz.de:120666$$pVDB
000120666 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b12aaacaa142dabed85c6d84d00bf0fb$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000120666 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000120666 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2e5f34f1c58eda4787a14c9dc139ca5f$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000120666 9101_ $$0I:(DE-HGF)0$$6P:(DE-He78)4e65d94adf590f6462ef8e3aa8d7f56f$$aExternal Institute$$b8$$kExtern
000120666 9101_ $$0I:(DE-HGF)0$$6P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab$$aExternal Institute$$b9$$kExtern
000120666 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1042737c83ba70ec508bdd99f0096864$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000120666 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d99bad949ba3ae93859eedae5ac266da$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000120666 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d84ca2cd7f160904c387ee699735076c$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000120666 9131_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000120666 9141_ $$y2017
000120666 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000120666 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000120666 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000120666 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000120666 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J CANCER : 2015
000120666 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000120666 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000120666 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000120666 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000120666 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000120666 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000120666 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000120666 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000120666 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000120666 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J CANCER : 2015
000120666 9201_ $$0I:(DE-He78)F020-20160331$$kF020$$lInfektionen und Krebs-Epidemiologie$$x0
000120666 9201_ $$0I:(DE-He78)G405-20160331$$kG405$$lMolekulare Grundlagen von HNO-Tumoren$$x1
000120666 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x2
000120666 980__ $$ajournal
000120666 980__ $$aVDB
000120666 980__ $$aI:(DE-He78)F020-20160331
000120666 980__ $$aI:(DE-He78)G405-20160331
000120666 980__ $$aI:(DE-He78)C060-20160331
000120666 980__ $$aUNRESTRICTED